Skip to main content

Table 1 Characteristics of patients with Sjӧgren’s syndrome and dry mouth

From: New low-dose liquid pilocarpine formulation for treating dry mouth in Sjögren’s syndrome: clinical efficacy, symptom relief, and improvement in quality of life

Number of patients (male / female) 24 (0/24)
Average age (years) a 61.8 ± 13.4
Salivary secretion (g/30 s.) a 0.076 ± 0.092
Major complications (cases)
 Osteoporosis 10
 Rheumatism 7
 Hypertension 7
 Refractory gastroesophageal reflux disease 6
 Keratitis 6
 Diabetic 5
 Hyperlipidemia 5
 Systemic scleroderma 4
 Insomnia 4
Clinical laboratory tests
 Anti-SS-A b antibody (cases)  
   > 5 U/mL 17
   < 5 U/mL 7
 IgG (cases)  
   < 800 mg/dL 2
  800–1700 mg/dL 9
   > 1700 mg/dL 11
 Serum creatinine (mg/dL) a 0.75 ± 0.24
 Blood urea nitrogen (mg/dL) a 14.6 ± 4.6
 Aspartate aminotransferase (U/L) a 23 ± 11
 Alanine aminotransferase (U/L) a 17 ± 7
  1. a: Where indicated, data are expressed as means ± SD
  2. b: Anti-Sjögren’s syndrome-related antigen A